rifapentine
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
3 FDA-registered drug labelers
Cohance Lifesciences Limited
Interquim, S.A. de C.V.
sanofi-aventis U.S. LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Priftin
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Rifapentine Tablet, Film Coated
03/25/2020Available
Chemical Identity
CAS61379-65-5
PubChem CID135403821
DTXSIDDTXSID8041115
FormulaC47H64N4O12
Mol. Weight877 g/mol
SMILESCC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C
Data Sources
1354038212026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/rifapentine/cids/JSON
Archive: data/sources/pubchem_name/rifapentine.json
CAS 61379-65-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 61379-65-52026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json